Athyrium Capital Management

Latest statistics and disclosures from Athyrium Capital Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are Omeros Corp, BIOR, PBYI, and represent 100.00% of Athyrium Capital Management's stock portfolio.
  • Reduced shares in these 1 stock: PBYI.
  • Athyrium Capital Management was a net seller of stock by $-2.8M.
  • Athyrium Capital Management has $73M in assets under management (AUM), dropping by 5.75%.
  • Central Index Key (CIK): 0001728001

Tip: Access up to 7 years of quarterly data

Positions held by Athyrium Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Athyrium Capital Management

Athyrium Capital Management holds 3 positions in its portfolio as reported in the March 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Omeros Corp Note 5.250% 2/1 (Principal) 74.3 $54M 73M 0.74
 View chart
Biora Therapeutics Com New (BIOR) 16.5 $12M 11M 1.10
 View chart
Puma Biotechnology (PBYI) 9.1 $6.7M -29% 1.3M 5.30
 View chart

Past Filings by Athyrium Capital Management

SEC 13F filings are viewable for Athyrium Capital Management going back to 2017

View all past filings